BADGE (Synonyms: Bisphenol A diglycidyl ether, DGEBA, NSC 5022) |
| رقم الكتالوجGC13829 |
PPARγ antagonist
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1675-54-3
Sample solution is provided at 25 µL, 10mM.
منتجات GlpBio المذكورة في الأوراق ذات السمعة الطيبة
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >85.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 1675-54-3 | SDF | |
| المرادفات | Bisphenol A diglycidyl ether, DGEBA, NSC 5022 | ||
| Chemical Name | (2S,2'S)-2,2'-(((propane-2,2-diylbis(4,1-phenylene))bis(oxy))bis(methylene))bis(oxirane) | ||
| Canonical SMILES | CC(C(C=C1)=CC=C1OC[C@H]2OC2)(C)C(C=C3)=CC=C3OC[C@H]4OC4 | ||
| Formula | C21H24O4 | M.Wt | 340.42 |
| الذوبان | ≥ 34mg/mL in DMSO | Storage | Desiccate at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 2.9375 mL | 14.6877 mL | 29.3755 mL |
| 5 mM | 0.5875 mL | 2.9375 mL | 5.8751 mL |
| 10 mM | 0.2938 mL | 1.4688 mL | 2.9375 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GN10505 Crocin
- GC17140 GR 127935 hydrochloride
- GC35334 Amyloid β Peptide (42-1)(human)
- GC14605 Nocistatin (human)
- GC16599 CPI-169
- GC19123 Delpazolid
- GC43917 Isopropyl Benzenesulfonate
- GC36881 PF-04937319
- GC35514 BI-4916
- GC32262 CP-28888 (CP 28888-27)
- GC42713 ACTH (1-10) (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt)
- GC41054 JWH 122 7-methylnaphthyl isomer
- GC13934 [Leu31,Pro34]-Neuropeptide Y (porcine)
- GC36510 LY3130481
- GC10634 MCC950 sodium
- GC14142 Acetylcholine Chloride
مراجعات
Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *